联邦制的负担：各州控制处方药成本尝试面临的挑战。 - Suppr

Suppr

超能文献

The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs.

作者信息

Gudiksen Katherine L, King Jaime S

出版信息

J Leg Med. 2019 Apr-Jun;39(2):95-120. doi: 10.1080/01947648.2019.1645541.

DOI:10.1080/01947648.2019.1645541

PMID:31503534

Abstract

摘要

相似文献

The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs.

J Leg Med. 2019 Apr-Jun;39(2):95-120. doi: 10.1080/01947648.2019.1645541.

Prescription-drug prices.

N Engl J Med. 2004 Sep 30;351(14):1375-7. doi: 10.1056/NEJMp048158.

States on the Front Line: Addressing America's Drug Pricing Problem.

J Leg Med. 2019 Apr-Jun;39(2):81-93. doi: 10.1080/01947648.2019.1645544.

An Incomplete Prescription: President Trump's Plan to Address High Drug Prices.

JAMA. 2018 Jun 19;319(23):2373-2374. doi: 10.1001/jama.2018.7424.

Value-Based Pricing and State Reform of Prescription Drug Costs.

JAMA. 2017 Aug 15;318(7):609-610. doi: 10.1001/jama.2017.8255.

Pharmaceuticals and medical devices: Medicare Part D. Issue brief.

Issue Brief Health Policy Track Serv. 2012 Dec 31:1-32.

Government commitment and regulation of prescription drugs.

Health Aff (Millwood). 2003 May-Jun;22(3):46-8. doi: 10.1377/hlthaff.22.3.46.

The Pay-Twice Critique, Government Funding, and Reasonable Pricing Clauses.

J Leg Med. 2019 Apr-Jun;39(2):177-211. doi: 10.1080/01947648.2019.1648942.

McKesson settling up. $190 million payment latest in drug-price flap.

Mod Healthc. 2012 Apr 30;42(18):14.

Can price and regulatory controls replace free market competition in the drug industry?

Healthspan. 1993 Nov;10(10):30-2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs.

作者信息

Gudiksen Katherine L, King Jaime S

出版信息

J Leg Med. 2019 Apr-Jun;39(2):95-120. doi: 10.1080/01947648.2019.1645541.

DOI:10.1080/01947648.2019.1645541

PMID:31503534

Abstract

摘要

相似文献

The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs.

J Leg Med. 2019 Apr-Jun;39(2):95-120. doi: 10.1080/01947648.2019.1645541.

Prescription-drug prices.

N Engl J Med. 2004 Sep 30;351(14):1375-7. doi: 10.1056/NEJMp048158.

States on the Front Line: Addressing America's Drug Pricing Problem.

J Leg Med. 2019 Apr-Jun;39(2):81-93. doi: 10.1080/01947648.2019.1645544.

An Incomplete Prescription: President Trump's Plan to Address High Drug Prices.

JAMA. 2018 Jun 19;319(23):2373-2374. doi: 10.1001/jama.2018.7424.

Value-Based Pricing and State Reform of Prescription Drug Costs.

JAMA. 2017 Aug 15;318(7):609-610. doi: 10.1001/jama.2017.8255.

Pharmaceuticals and medical devices: Medicare Part D. Issue brief.

Issue Brief Health Policy Track Serv. 2012 Dec 31:1-32.

Government commitment and regulation of prescription drugs.

Health Aff (Millwood). 2003 May-Jun;22(3):46-8. doi: 10.1377/hlthaff.22.3.46.

The Pay-Twice Critique, Government Funding, and Reasonable Pricing Clauses.

J Leg Med. 2019 Apr-Jun;39(2):177-211. doi: 10.1080/01947648.2019.1648942.

McKesson settling up. $190 million payment latest in drug-price flap.

Mod Healthc. 2012 Apr 30;42(18):14.

Can price and regulatory controls replace free market competition in the drug industry?

Healthspan. 1993 Nov;10(10):30-2.